| Vitamin D and Multiple Sclerosis: A Comprehensive Review |
39 |
| A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) |
15 |
| Emerging Immunotherapies for Parkinson Disease |
14 |
| Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive DyskinesiaKey Differences in Pathophysiology and Clinical Management |
13 |
| Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations |
11 |
| A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment |
9 |
| Phase 1 Parkinson's Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated |
9 |
| Salivary Biomarkers for Alzheimer's Disease and Related Disorders |
9 |
| Fingolimod Immune Effects Beyond Its Sequestration Ability |
8 |
| A Review on MS-Based Blood Biomarkers for Alzheimer's Disease |
8 |
| 5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress |
8 |
| Deep Learning and Neurology: A Systematic Review |
8 |
| Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders |
7 |
| Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes |
7 |
| Diagnosing and Treating Depression in Patients with Alzheimer's Disease |
7 |
| Reflections on the Utility of the Retina as a Biomarker for Alzheimer's Disease: A Literature Review |
6 |
| Late Onset of Neuromyelitis Optica Spectrum Disorders |
6 |
| Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy (c) Application |
6 |
| Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers |
6 |
| Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment |
5 |
| A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study |
5 |
| An Update on Blood-Based Markers of Alzheimer's Disease Using the SiMoA Platform |
5 |
| Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS) |
5 |
| Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review |
5 |
| Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population |
5 |
| Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer |
5 |
| Critical Steps to be Taken into Consideration Before Quantification of beta-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment |
4 |
| Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms |
4 |
| Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children |
4 |
| Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques |
4 |
| A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson's Disease |
3 |
| Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project |
3 |
| Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis |
3 |
| Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology |
3 |
| Neurophysiological Markers of Alzheimer's Disease: Quantitative EEG Approach |
3 |
| ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 x Ob1)F1 Mice by Induction of IL-10-Secreting iTregs |
2 |
| Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review |
2 |
| Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson's Disease |
2 |
| Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial |
2 |
| The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications |
2 |
| Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies |
2 |
| Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials |
2 |
| Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? |
2 |
| Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson's Disease |
2 |
| PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit |
1 |
| Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report |
1 |
| A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia |
1 |
| Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series |
1 |
| Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital |
1 |
| Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance |
1 |
